|
|
 |
|
Viewing report
|
|
|
Biomarker Research in Parkinson's Disease
Future Medicine Ltd, Oct 2010, Pages: 92
The concept of 'personalized medicine' has reached the forefront of neurodegenerative diseases. There is a need for objective markers of Parkinson's disease that can indicate the biological processes underlying each variant of the disease. In this way, variant-specific trial enrollment is promoted and, in the future, successful treatment plans can be devised.
The October issue of Biomarkers in Medicine covers several aspects of Parkinson's disease biomarker research, including relevance and classification, functional analysis of neural tissue, interrogation of biological fluids, and assessment of genetic traits. In addition, the issue features unique reports from the perspectives of funding agencies and venture capitalists.
Product samples
A sample for this product is available. Please Login/Register to download this sample.
|
|
|
|
